Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Osteoblast adhesion of breast cancer cells with scanned image microscopy
Chiaki Miyasaka
, Bernhard R. Tittmann
, Robyn R. Mercer
, Andrea M. Mastro
Engineering Science and Mechanics
Materials Research Institute (MRI)
Biochemistry & Molecular Biology
Penn State Cancer Institute
Cancer Institute, Mechanisms of Carcinogenesis
Research output
:
Contribution to journal
›
Conference article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Osteoblast adhesion of breast cancer cells with scanned image microscopy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Microscopy
100%
Breast Cancer Cells
100%
Conditioned Medium
100%
MDA-MB-231
100%
Osteoblast Adhesion
100%
Scanned Image
100%
MC3T3-E1 Cells
75%
Acoustic Reflection
75%
Adhesion
50%
MC3T3-E1
50%
Cell Culture
25%
Bone Tissue
25%
MDA-MB-231 Cancer Cells
25%
Cell Adhesion
25%
Breast Cancer
25%
Cancer Cells
25%
Osteoclast
25%
Microscopic Techniques
25%
Metastasizing
25%
Metastatic Breast Cancer
25%
New Bone
25%
Osteoblast Cells
25%
Substrate Interface
25%
Large Lesions
25%
Mechanical Scanning
25%
Abnormal Shape
25%
Plastic Substrate
25%
Optical Microscopic
25%
Osteoclast Cells
25%
Medicine and Dentistry
Breast Cancer
100%
Cancer Cell
100%
MC3T3
100%
Osteoblast
100%
Osteoclast
40%
Cell Adhesion
20%
Breast Cancer Cell Line
20%
Bone Tissue
20%
Metastatic Breast Cancer
20%
Immunology and Microbiology
Cancer Cell
100%
Osteoblast
100%
Osteoclast
50%
Light Microscopy
25%
Breast Cancer Cell Line
25%
Cell Adhesion
25%
Bone Tissue
25%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Osteoblast
100%
Osteoclast
40%
Cell Adhesion
20%
Optics
20%
Engineering
Conditioned Medium
100%
Osteoblast Cell
50%
Substrate Interface
25%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Malignant Neoplasm
25%
Metastatic Breast Cancer
25%